Baird initiated coverage of HCA Healthcare with an Outperform rating and $396 price target. The firm started coverage on three Hospital companies with two having Outperform ratings and one with a Neutral rating. Baird believes Hospitals remain well positioned in 2024 to outperform expectations, but long term it remains cautious on the potential secular headwind that could be driven by Value Based Care, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare SVP Torres sells 1,863 common shares
- Appaloosa takes new positions in Adobe and Boeing, boosts Alibaba stake
- HCA Healthcare initiated with a Buy at DBS Bank
- HCA Healthcare CFO Retires, New Directors Elected, Proposals Voted
- HCA Healthcare price target lowered to $360 from $371 at TD Cowen